So much learned in 1 year of COVID-19 – Mayo Clinic News Network

The COVID-19 pandemic has discovered how swiftly everyday living can alter. That is evident in people’s own life and throughout the scientific local community. Exceptional improvements have been produced in science in excess of the past year, guided by worldwide exploration collaborations.

“When you glimpse at 9 months from when we initially identified this pathogen to owning a vaccine, that’s as shut to a human miracle, if I could use that phrase, as as one particular could be expecting,” says Dr. Gregory Poland, an infectious diseases qualified and head of Mayo Clinic’s Vaccine Investigation Group.

But he claims there have been some frustrations. “As shortly as we make some progress, all people would like to open up and take it easy limits,” states Dr. Poland. “Opening up and having again to regular is not a gentle change.”

In this Mayo Clinic Q&A podcast, Dr. Poland talks about classes realized during the COVID-19 pandemic, and that vaccinations aren’t ample to defeat the COVID-19 virus and variants. He also states that speaking science and community health messaging requires to strengthen in the foreseeable future.

Look at: Dr. Poland discusses the personalized and scientific classes acquired the the COVID-19 pandemic.

Read through the full transcript.


For the security of its individuals, staff members and readers, Mayo Clinic has strict masking procedures in area. Anyone revealed with no a mask was either recorded prior to COVID-19 or recorded in a nonpatient treatment location where social distancing and other security protocols ended up followed.

Facts in this post was exact at the time of its posting. Due to the fluid mother nature of the COVID-19 pandemic, scientific knowledge, along with guidelines and suggestions, might have changed since the authentic publication date

Dr. Poland has served as a expert for Merck & Co. Inc., Medicago Inc., GlaxoSmithKline plc, Sanofi Pasteur, Emergent BioSolutions Inc., Dynavax Technologies Corp., Genentech Inc., Eli Lilly and Co., Kentucky BioProcessing Inc. and Genevant Sciences Corp.and Janssen Prescription drugs Inc. He is a compensated scientific adviser for Johnson & JohnsonHonoraria: Elsevier.

For far more details and all your COVID-19 protection, go to the Mayo Clinic Information Network and

Learn a lot more about tracking COVID-19 and COVID-19 trends.